Clinical Trials in Maryland

Showing 681-700 of 11,119 trials

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

NCT06960213

This study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.

Hereditary AngioedemaHAEHereditary Angioedema - Type 1+1 more

ADARx Pharmaceuticals, Inc.90 participantsStarted Aug 2025

Little Rock, Arkansas, United States • Walnut Creek, California, United States • Wheaton, Maryland, United States +11 more locations

ACTIVE_NOT_RECRUITINGPHASE217 miles

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

NCT05686551

This study will evaluate the safety, biomarkers, and efficacy of tominersen compared with placebo in participants with prodromal and early manifest Huntington's Disease (HD).

Huntington Disease

Hoffmann-La Roche301 participantsStarted Feb 2023

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sacramento, California, United States +67 more locations

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

Find Trials by Condition in Maryland

ADVENT Post Approval Study

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Mobile Health for Adherence in Breast Cancer Patients

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Oxytocin Effects on Bone in Children With Autism Spectrum Disorder

Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)